Clinical trials near you

Clinical trials in the Omaha area

Name: Clinical trials in the Omaha area
Creator: LocalTrial
License: https://creativecommons.org/licenses/by/4.0/

396 studies are recruiting volunteers at 196 research sites in the Omaha, NE-IA area.

Sites in Omaha, Papillion, Council Bluffs, Bellevue, Elkhorn, Blair and 3 more towns.

#59 in the US for recruiting studies#1 in Nebraska#32 in the US per resident

Studies recruiting: 396
Research sites: 196
Conditions studied: 110
Studies per 100,000 residents: 39.6

Conditions being studied

The conditions with the most studies recruiting in the area. A study can be for more than one condition.

Lung cancer33 studies
Prostate cancer31 studies
Breast cancer30 studies
Head and neck cancer24 studies
Colorectal cancer (bowel cancer)23 studies
Non-Hodgkin's lymphoma19 studies
Kidney cancer16 studies
Leukemia15 studies
Ovarian cancer14 studies
Neuroendocrine tumor13 studies
Pancreatic cancer13 studies
Uterine cancer13 studies
Bladder cancer11 studies
Melanoma11 studies
Multiple myeloma (MM)11 studies

All 110 conditions

Lung cancer33
Prostate cancer31
Breast cancer30
Head and neck cancer24
Colorectal cancer (bowel cancer)23
Non-Hodgkin's lymphoma19
Kidney cancer16
Leukemia15
Ovarian cancer14
Neuroendocrine tumor13
Pancreatic cancer13
Uterine cancer13
Bladder cancer11
Melanoma11
Multiple myeloma (MM)11
Skin cancer11
Sarcoma of soft tissue10
Endometrial cancer9
Esophageal cancer9
Gastric cancer (stomach cancer)8
Liver cancer8
Liver disease8
Migraine8
Type 2 diabetes8
Alopecia6
Cardiovascular disease6
Cervical cancer6
Heart failure6
High blood pressure (hypertension)6
Alopecia areata5
COVID-195
Gastrointestinal stromal tumor5
Overweight and obesity5
Peripheral vascular disease5
Asthma4
Cardiomyopathy4
Chronic obstructive pulmonary disease (COPD)4
Epilepsy4
Ischemic heart disease (IHD)4
Congenital heart disease3
Hearing loss3
Myelodysplastic syndrome (MDS)3
Urinary incontinence3
Anemia2
Bile duct cancer2
Biliary tract cancer2
Brain cancer2
Cerebral palsy2
Chronic kidney disease (CKD)2
Chronic skin ulcer2
Depressive disorder2
Down syndrome2
Fallopian tube cancer2
Hidradenitis suppurativa (HS)2
Hodgkin's lymphoma2
Influenza (flu)2
Intellectual disability2
Interstitial lung disease2
Neuroblastoma2
Osteoarthritis (OA)2
Overactive bladder (OAB)2
Post-transplant lymphoproliferative disorder2
Pulmonary hypertension2
Rhabdomyosarcoma2
Schizophrenia2
Sickle cell disease2
Stroke2
Systemic lupus erythematosus (SLE)2
Testicular cancer2
Traumatic brain injury2
Urethral cancer2
Abdominal cancer1
Acne1
Acute coronary syndrome1
Age-related macular degeneration (AMD)1
Alcohol dependence1
Alzheimer's disease1
Amyloidosis1
Anal cancer1
Anxiety disorder1
Atrial fibrillation (AF)1
Attention-deficit hyperactivity disorder (ADHD)1
Bipolar disorder1
Cancer of unknown primary site (CUP)1
Dry eye syndrome1
Eczema (atopic dermatitis)1
Familial multiple polyposis syndrome1
Gallbladder cancer1
Germ cell tumor1
Glaucoma1
Gout1
Graves' disease1
Growth hormone deficiency1
Human immunodeficiency virus infection (HIV)1
Huntington's disease (HD)1
Hypercholesterolemia1
Multiple sclerosis (MS)1
Myelofibrosis1
Ocular hypertension1
Parkinson's disease (PD)1
Peritoneal cancer1
Psychotic disorder1
Retinal degeneration1
Schizoaffective disorder1
Short-sightedness (myopia)1
Thyroid cancer1
Ureteral cancer1
Vaginal cancer1
Vitiligo1
Vulvar cancer1

81 more studies are for conditions not yet in our catalog.

Whom the studies accept

The share of the area's studies open to each group. A study can accept several.

Adults 18 to 6490%
Adults 65 and over80%
Children and teens (under 18)26%
Healthy volunteers11%
Open to all sexes87%
Women only6%
Men only7%

33 studies are for children only.

Study phases

Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.

Early phase 11%
Phase 16%
Phase 1/27%
Phase 217%
Phase 2/33%
Phase 341%
Phase 43%
No phase (device, behavioral and other studies)14%
Not stated8%

Most active research sites

The sites recruiting for the most studies in the area.

Nebraska Cancer SpecialistsOmaha57 studies
Nebraska Medicine-Village PointeOmaha43 studies
Nebraska Medicine-BellevueBellevue41 studies
Children's Hospital and Medical Center of OmahaOmaha26 studies
Nebraska Methodist HospitalOmaha25 studies
Alegent Health Bergan Mercy Medical CenterOmaha23 studies
Alegent Health Immanuel Medical CenterOmaha21 studies
Alegent Health Lakeside HospitalOmaha21 studies
Nebraska Cancer Specialists/Oncology Hematology West PC - MECCOmaha18 studies
University of Nebraska Medical CenterOmaha14 studies
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NEOmaha13 studies
Skin SpecialistsOmaha10 studies
Creighton University Medical CenterOmaha9 studies
Velocity Clinical Research, OmahaOmaha9 studies
XCancer Omaha LLCOmaha9 studies

Cite these figures

Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.

As text

Source: LocalTrial, Clinical trials in the Omaha area, https://www.localtrial.com/clinical-trials/nebraska/omaha, updated November 12, 2026.

With the link, for a web page

Source: <a href="https://www.localtrial.com/clinical-trials/nebraska/omaha">LocalTrial, Clinical trials in the Omaha area</a>, updated November 12, 2026.

About these figures

Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States. A study is counted once however many sites it has in the area.

The area is the U.S. Census Bureau's Omaha, NE-IA metropolitan area. Residents: 1,001,010, the Census Bureau's latest estimate. Updated November 12, 2026.

These figures describe studies, not advice. Talk to your doctor before joining one.

Tell us a little about yourself and we'll suggest the studies near you that may fit. Free and private.

Ready to see what's near you?

Get matched